Ms. Goodfellow has over twenty years experience in clinical programs management. She was most recently Associate Director, Clinical Operations for BiogenIdec where she had planning, execution, and oversight responsibility of a global Phase III trial of Ritxuan for rheumatoid arthritis. She also managed clinical trials for several additional compounds for oncologic indications. Previously, Ms. Goodfellow was Regional Manager for Novo Nordisk where she had clinical operations responsibility for numerous Phase I-IV studies. She has also served in clinical research positions for Iomed, Anesta, and Symbion. Ms. Goodfellow holds a B.A. from the University of Utah.